accounta major surprise to us and another setback for Abbott���s cholesterol franchise,��� Larry Biegelsen, an analyst at Wells Fargo in New York, said today in a note to clients. He estimated that sales of Niaspan may fall by 20 percent to 30 percent as a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott���s Cholesterol Combo Fails to Protect Heart in Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account